Financials
- Market Capitalization 226.2 M
- Employee 130
- Founded 2016
- CEO N/A
- Website www.nautilus.bio
- Headquarter Washington, United States
- FIGI BBG00W7G4M12
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-4.15
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3536 | TARA Protara Therapeutics, Inc. - Common Stock | 4.13 USD | -1.20% | -7.61% | +4.82% | +29.87% | 232.12 M USD | ||
| 3550 | DTIL Precision BioSciences, Inc. - Common Stock | 8.80 USD | +2.44% | -4.24% | +42.39% | +91.30% | 227.06 M USD | ||
| 3560 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.76 USD | -1.57% | -5.76% | -8.74% | +23.68% | 225.15 M USD | ||
| 3562 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 9.91 USD | -1.39% | +2.59% | +2.69% | +2.80% | 224.59 M USD |